Bio-Techne Opens New Bristol Facility
Benzinga Newsdesk 3 weeks ago
News
Investment strengthens Bio-Techne's global GMP manufacturing infrastructure for cell therapy applicationsNew Bristol facility expands GMP small molecule production capacity and complements recent investments in
- Investment strengthens Bio-Techne's global GMP manufacturing infrastructure for cell therapy applications
- New Bristol facility expands GMP small molecule production capacity and complements recent investments in North America
- Combined capabilities across Bristol, St. Paul and Minneapolis support customers from discovery through commercial manufacturing